These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27012262)

  • 21. What works, and what remains to be done, in HIV prevention in the United States.
    Holtgrave DR; Curran JW
    Annu Rev Public Health; 2006; 27():261-75. PubMed ID: 16533117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdisciplinary translational behavioral (TDTB) research: opportunities, barriers, and innovations.
    Czajkowski SM; Lynch MR; Hall KL; Stipelman BA; Haverkos L; Perl H; Scott MS; Shirley MC
    Transl Behav Med; 2016 Mar; 6(1):32-43. PubMed ID: 27012251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The costs of prevention.
    Weinstein MC
    J Gen Intern Med; 1990; 5(5 Suppl):S89-92. PubMed ID: 2231073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translating evidence into population health improvement: strategies and barriers.
    Woolf SH; Purnell JQ; Simon SM; Zimmerman EB; Camberos GJ; Haley A; Fields RP
    Annu Rev Public Health; 2015 Mar; 36():463-82. PubMed ID: 25581146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical preventive services: when is the juice worth the squeeze?
    Salinsky E
    Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (806):1-30. PubMed ID: 16136717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease on a global scale: defining the path forward for research and practice.
    Mark DB; Van de Werf FJ; Simes RJ; White HD; Wallentin LC; Califf RM; Armstrong PW;
    Eur Heart J; 2007 Nov; 28(21):2678-84. PubMed ID: 17940081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standards of Evidence for Conducting and Reporting Economic Evaluations in Prevention Science.
    Crowley DM; Dodge KA; Barnett WS; Corso P; Duffy S; Graham P; Greenberg M; Haskins R; Hill L; Jones DE; Karoly LA; Kuklinski MR; Plotnick R
    Prev Sci; 2018 Apr; 19(3):366-390. PubMed ID: 29435786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Economic evaluation of public health interventions].
    García-Altés A; Navas E; Soriano MJ
    Gac Sanit; 2011 Jun; 25 Suppl 1():25-31. PubMed ID: 22055548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A modelling tool for policy analysis to support the design of efficient and effective policy responses for complex public health problems.
    Atkinson JA; Page A; Wells R; Milat A; Wilson A
    Implement Sci; 2015 Mar; 10():26. PubMed ID: 25889919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of disease prevention in a morbidity-based financing system: does prevention pay off for a statutory health insurance fund in Germany?
    Weinhold I; Schindler C; Kossack N; Berndt B; Häckl D
    Eur J Health Econ; 2019 Nov; 20(8):1181-1193. PubMed ID: 31317353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome.
    Korczak D; Dietl M; Steinhauser G
    GMS Health Technol Assess; 2011 Apr; 7():Doc02. PubMed ID: 21468290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of public health interventions.
    Owen L; Morgan A; Fischer A; Ellis S; Hoy A; Kelly MP
    J Public Health (Oxf); 2012 Mar; 34(1):37-45. PubMed ID: 21933796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Pay for Success" Financing and Home-Based Multicomponent Childhood Asthma Interventions: Modeling Results From the Detroit Medicaid Population.
    Lantz PM; Miller G; Rhyan CN; Rosenbaum S; Ku L; Iovan S
    Milbank Q; 2018 Jun; 96(2):272-299. PubMed ID: 29870111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The way forward: maximizing our impact through shared responsibility and smart investments.
    Goosby E
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 2():S44-7. PubMed ID: 22772391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of a rapid response mechanism to meet policymakers' urgent needs for research evidence about health systems in a low income country: a case study.
    Mijumbi RM; Oxman AD; Panisset U; Sewankambo NK
    Implement Sci; 2014 Sep; 9():114. PubMed ID: 25208522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention research and its actual application to health services.
    Holder HD
    J Behav Health Serv Res; 2001 May; 28(2):118-29. PubMed ID: 11338324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scaling-up impact in perinatology through systems science: Bridging the collaboration and translational divides in cross-disciplinary research and public policy.
    Munar W; Hovmand PS; Fleming C; Darmstadt GL
    Semin Perinatol; 2015 Aug; 39(5):416-23. PubMed ID: 26184341
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.